Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/09/2859875/0/en/Vanqua-Bio-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-Evaluating-VQ-101-its-Small-Molecule-GCase-Activator-for-GBA-Parkinson-s-Disease-and-Related-Disorders.html
https://www.globenewswire.com//news-release/2024/03/13/2845315/0/en/Vanqua-Bio-to-Present-at-the-Stifel-2024-CNS-Days-Conference.html
https://www.globenewswire.com//news-release/2024/02/27/2835893/0/en/Vanqua-Bio-to-Present-Pre-Clinical-Data-on-VQ-101-a-Novel-GCase-Activator-For-The-Treatment-of-GBA-Parkinson-s-Disease.html
https://www.globenewswire.com//news-release/2023/12/12/2794631/0/en/Vanqua-Bio-Advances-Clinical-Candidate-for-Parkinson-s-Disease-Expands-Leadership-Team-to-Support-Further-Development.html
https://www.globenewswire.com//news-release/2023/10/18/2762231/0/en/Vanqua-Bio-to-Participate-in-the-Leerink-Partners-Biopharma-Private-Company-Connect.html
https://www.globenewswire.com/news-release/2023/03/22/2632087/0/en/Vanqua-Bio-to-Present-at-the-Stifel-2023-CNS-Day-Conference.html
https://www.globenewswire.com/news-release/2022/03/24/2409297/0/en/Vanqua-Bio-to-Present-at-the-Stifel-2022-CNS-Day-Conference.html